Cerebral kinetics of the dopamine D2 receptor ligand [123I]IBZM in mice

Nuclear Medicine and Biology

Volumn 35, Issue 4, 2008, Pages 467-473

  Meyer, Philipp T ^a   Salber, Dagmar ^b   Schiefer, Johannes ^a   Cremer, Markus ^c   Schaefer, Wolfgang M ^a   Kosinski, Christoph M ^a   Langen, Karl Josef ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

123I IBZM; Dopamine D2 receptor; Isoflurane anaesthesia; Small animal imaging; SPECT; Tracer kinetic analysis

Indexed keywords

ISOFLURANE; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE I 123; RADIOPHARMACEUTICAL AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG UPTAKE; MOUSE; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANESTHESIA; ANESTHETICS, INHALATION; ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; BRAIN; ISOFLURANE; KINETICS; MICE; MODELS, ANIMAL; PYRROLIDINES; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 43049175025     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.01.002     Document Type: Article

References (40)

1. 18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging 33 (2006) 948-954
2. Acton P.D., Choi S.R., Plossl K., and Kung H.F. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography. Eur J Nucl Med Mol Imaging 29 (2002) 691-698
3. 123]IBF. Eur J Nucl Med Mol Imaging 29 (2002) 1507-1515
4. Saji H., Iida Y., Kawashima H., Ogawa M., Kitamura Y., Mukai T., et al. In vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography. Anal Sci 19 (2003) 67-71
5. 2 receptor availability in rats. Neuroimage 24 (2005) 822-831
6. Vastenhouw B., and Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med 48 (2007) 487-493
7. 125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. Int J Rad Appl Instrum B 15 (1988) 195-201
8. Neumeyer J.L., Wang S., Gao Y., Milius R.A., Kula N.S., Campbell A., et al. N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 37 (1994) 1558-1561
9. 2 receptors with specific iodinated markers in a rat model of Parkinson's disease. Synapse 31 (1999) 134-139
10. 2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide. Neurosci Lett 288 (2000) 71-75
11. 2 receptor in competition with haloperidol and endogenous dopamine - an in vivo imaging study with a dedicated small animal SPECT. Eur J Nucl Med Mol Imaging 32 (2005) 1305-1310
12. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
13. Cha J.H., Kosinski C.M., Kerner J.A., Alsdorf S.A., Mangiarini L., Davies S.W., et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci U S A 95 (1998) 6480-6485
14. 125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT. Life Sci 42 (1988) 2097-2104
15. 2 antagonist and agonist. Brain Res 453 (1988) 393-396
16. Slifstein M., and Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 28 (2001) 595-608
17. Camps M., Kelly P.H., and Palacios J.M. Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80 (1990) 105-127
18. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27 (2007) 1533-1539
19. 123I]IBZM) in rat and human brain. Int J Rad Appl Instrum B 18 (1991) 837-846
20. 125I-IBZM and its biodistribution and kinetic properties. Kaku Igaku 31 (1994) 513-519 [Japanese]
21. 2 dopamine receptors - a basis for semiquantitative measurement of the receptor density using equilibrium analysis. Kaku Igaku 31 (1994) 1117-1120 [Japanese]
22. 2 receptor binding of [(123)I]AIBZM and [(123)I]IBZM in rat brain. Nucl Med Biol 28 (2001) 383-389
23. 123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. J Nucl Med 30 (1989) 88-92
24. 2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide. J Nucl Med 36 (1995) 384-393
25. 123I-FP-CIT SPECT: comparability of modern SPECT systems. J Nucl Med 44 (2003) 839-845
26. Laruelle M., Abi-Dargham A., van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36 (1995) 1182-1190
27. 2 receptor radioligands: 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med 32 (1991) 1593-1600
28. Kung M.P., Kung H.F., Billings J., Yang Y., Murphy R.A., and Alavi A. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J Nucl Med 31 (1990) 648-654
29. 2 dopamine receptor binding in the living human brain by PET. Science 231 (1986) 258-261
30. 11C]raclopride binding. J Cereb Blood Flow Metab 18 (1998) 941-950
31. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 13 (1993) 24-42
32. 18F-FDG PET studies in mice. J Nucl Med 47 (2006) 999-1006
33. Opacka-Juffry J., Ahier R.G., and Cremer J.E. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia. Synapse 7 (1991) 169-171
34. 2 and other G-linked receptors. Synapse 50 (2003) 35-40
35. Tsukada H., Nishiyama S., Kakiuchi T., Ohba H., Sato K., Harada N., et al. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 849 (1999) 85-96
36. Lenz C., Rebel A., van Ackern K., Kuschinsky W., and Waschke K.F. Local cerebral blood flow, local cerebral glucose utilization, and flow-metabolism coupling during sevoflurane versus isoflurane anesthesia in rats. Anesthesiology 89 (1998) 1480-1488
37. Okamoto H., Meng W., Ma J., Ayata C., Roman R.J., Bosnjak Z.J., et al. Isoflurane-induced cerebral hyperemia in neuronal nitric oxide synthase gene deficient mice. Anesthesiology 86 (1997) 875-884
38. Thompson J.S., Brown S.A., Khurdayan V., Zeynalzadedan A., Sullivan P.G., and Scheff S.W. Early effects of tribromoethanol, ketamine/xylazine, pentobarbitol, and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. Comp Med 52 (2002) 63-67
39. Watkins III J.B., Engles D.R., and Beck L.V. Effect of volatile anesthetics on the hepatic UDP-glucuronic acid pathway in mice. Biochem Pharmacol 40 (1990) 731-735
40. Buzaleh A.M., Enriquez de Salamanca R., and del Carmen Batlle A.M. Administration of the anesthetic isoflurane to mice: a model for acute intermittent porphyria?. J Pharmacol Toxicol Methods 28 (1992) 191-197